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Abstract 
In the last decades, cyclometalated Ir(III) complexes have drawn a large interest for their unique 
properties: they are excellent triplet state emitters, thus the emission is phosphorescent in 
nature; typically high quantum yields and good stability make them good candidates for 
luminescent materials. Moreover, through an opportune choice of the ligands, it is possible to 
tune the emission along the whole visible spectra. Thanks to these interesting features, Ir(III) 
complexes have found different applications in several areas of applied science, from OLEDs 
to bioimaging. In particular, regarding the second application, a remarkable red-shift in the 
emission is required, in order to minimize the problem of the tissue penetration and the possible 
damages for the organisms.  
With the aim of synthesizing a new family of NIR emitting Ir(III) complexes, we envisaged the 
possibility to use for the first time 2-(1H-tetrazol-1-yl)pyridine as bidentate ligand able to 
provide the required red-shift of the emission of the final complexes.  
Exploiting the versatility of the ligand, I prepared two different families of heteroleptic Ir(III) 
complexes. In detail, in the first case the 2-(1H-tetrazol-1-yl)pyridine was used as bis-chelating 
N^N ligand, leading to cationic complexes, while in the second case it was used as 
cyclometalating C^N ligand, giving neutral complexes. 
The structures of the prepared molecules have been characterised by NMR spectroscopy and 
mass spectrometry. Moreover, the neutral complexes’ emissive properties have been measured: 
emission spectra have been recorded in solution at both room temperature and 77K, as well as 
in PMMA matrix. DFT calculation has then been performed and the obtained results have been 
compared to experimental ones.  
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Introduction 
1. Luminescence 
The term Luminescence (Lichetereggung in German) was firstly introduced by a German 
physics, Eilhard Wiedemann, in 1888. This phenomenon consists in the emission of light from 
an excited compound.  
In general, when a molecule absorbs energy it is promoted to an excited state, from which it 
returns to the ground state releasing energy, in most cases in the form of heat. However, in some 
cases, the release of the absorbed energy can take place through the emission of photons, then 
luminescence occurs. 
Depending on the type of excitation, there could be different types of luminescence: 
Chemoluminescence – the emission is the result of a chemical reaction that generates the 
product in its excited state; the decay to the ground state occurs releasing photons; 
Mechanoluminescence – the emission is generated through any mechanical action on a solid: 
in some cases you have to break the bonds (Triboluminescence), in others, just a mild elastic 
deformation is enough (Piezoluminescence); 
Electroluminescence – the emission is generated when an electric current is applied on the 
material; 
Thermoluminescence – the emission is generated when the material is heated. It is a property 
of certain crystalline materials; 
Photoluminescence – the emission is generated through the absorption of an electromagnetic 
radiation (typically UV-Vis photons); the absorbed energy is released as photons with lower 
energy.  
Among luminescence phenomena, two different processes can be observed:  
1) The light emission is immediate, but stops once the source of excitation is turned 
off. 
2) The light emission is not immediate, but persistent, even when the source of 
excitation is turned off; 
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The first case described is called Fluorescence, while the second is called Phosphorescence. 
The differences between these two kinds of emission are well described by Jablonski diagram,1  
where the energy level of the spin multiplicities are represented. The limits of electronic energy 
states are represented by bold horizontal lines. The grey horizontal lines are different vibronic 
energy states. 
  
 
Figure 1. Jablonski diagram 
 
It is assumed that, at room temperature, almost all of the molecules are situated at the lowest 
energy level called the Ground State (S0). Absorption of an opportune wavelength can promote 
molecules to an electronic excited state (Sn). This state is not stable and the molecules can 
follow two deactivation paths: radiative decay (indicated with solid arrows) and non-radiative 
decay (indicated with dashed arrows). 
The non-radiative deactivation consists of three processes: 
 Vibrational relaxation: the loss of excitation energy through energy transfer to the 
environment caused by collisions (time ≈ 10-12 s); 
 Internal conversion: an isoenergetic transition between two electronic states of the 
same multiplicity (time ≈ 10-13 s); 
 Intersystem crossing: an isoenergetic transition between two electronic states with 
different multiplicity (time ≈ 10-8 s). 
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All this processes take place without the emission of photons. On the contrary, the radiative 
deactivation occurs with an emission of photon and two main processes can be identified for 
this kind of deactivation: 
 Fluorescence: a spin-allowed transition from the lowest excited singlet (S1) to the 
ground state (S0) (time ≈ 10
-9 s); 
 Phosphorescence: a spin-forbidden transition from the lowest excited triplet (T1) to 
the ground sate (S0) (time ≈ 10
-6 s); 
Several factors may increase the non-radiative decay: for example a high flexibility of the 
molecular structure, high temperatures, that cause the molecules to move faster and to collide 
more frequently, or the presence of a solvent, capable of absorbing the energy of excited 
molecules.  
The two kinds of decay are in competition between each other and fluorescence and 
phosphorescence are not commonly observed, especially in nature. 
Concerning radiative decay, once excited with the correct energy, a molecule can be promoted 
to an excited state (S0  Sn). Through internal conversion it can decay to the lowest excited 
state S1, from which it can either relax to S0 with the emission of a photon (fluorescence) or it 
can undergo the Intersystem crossing, leading to the population of Triplet state (S1  T1), and 
the following relaxation to the ground state S0 (phosphorescence). This latter process goes with 
the emission of a photon as well. In order to be competitive the Intersystem crossing should be 
efficient. The triplet states are situated at lower energy, so the phosphorescence emission occurs 
at longer wavelength than fluorescence. Furthermore, the transitions between states with 
different multiplicity are forbidden (T1  S0), so the relaxation time is longer than for the 
fluorescence emission. However, the transition became more accessible with the presence of 
heavy atoms with a big spin-orbit coupling, such as Ir(III) (3909 cm-1). For this reason, 
transition metal complexes are widely used for luminescent materials. 
The luminescent properties of compounds can be measured through various parameters, such 
as quantum yield and lifetime, together with the emission wavelengths.  
The quantum yield (Φ) is a parameter that quantifies the amount of light emitted by a molecule. 
Basically, it’s the ratio of emitted to absorbed photons. It takes in account two rate constants: 
the radiative rate constant (kr) and the non-radiative rate constant (knr):2 
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 Φ =
𝑘𝑟
𝑘𝑟 + 𝑘𝑛𝑟
 
While kr is quite clear, knr is trickier: it includes all the competing deactivation paths, such as 
intra- and intermolecular quenching of vibration energy relaxation. 
The average lifetime (τ) a molecule spends in its excited state, before the emission occurs, can 
be measured as well: 
τ =
1
𝑘𝑟 + 𝑘𝑛𝑟
 
In order to increase the quantum yield, the molecular structure should be rigid, to limit the 
vibrational relaxation deactivation path as much as possible. Depending on the process, heavy 
atoms should be used for the promotion of phosphorescence emission. On the other hand, lighter 
atoms should be used for the fluorescence emission. 
 
2. LED/OLED 
Among the plethora of possible applications of luminescent materials, one of the most 
interesting and most promising field is LEDs/OLEDs technology. The LED (Light-emitting 
diode) technology started to develop in the beginning of 20th century with the discovery of 
Electroluminescence. In 1927 the first LED was reported by the hand of a soviet inventor, Oleg 
Losev.3 However, only with Nick Holonyak Jr., an American inventor, the LED technology 
started to acquire a practical usage. Holonyak reported the creation of the first red LED in 1962.4 
His former student, M. G. Craford invented the first yellow LED in 1971,5 followed by the 
development of blue LED by H. P. Maruska the next year.6  
The LED is a light source which uses semiconductors and electroluminescence to create light. 
It consists of P-N junction, where “P” is the zone with electron holes, while “N” is a zone rich 
of electrons. When a suitable voltage is applied, the two zones combine at the junction, releasing 
photons, as illustrated in Figure 2. 
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Figure 2. LED structure 
 
The first possible application of LEDs is illumination, from street illumination to mobile 
displays. LEDs have been proven to be more efficient than conventional broad-spectrum light 
sources, such as metal halide or fluorescent lamps.7  Other advantages are their small mass and 
volume, solid-state construction, superior safety and longevity. In addition, LEDs can be used 
as an alternative source for plant biomass production: they can be used as a potential light source 
for growing plants in the space, where a sufficient quantity and quality of light is fundamental.8  
An OLED (Organic Light-emitting Diode) is a LED, in which an organic molecule, a polymer, 
or an organometallic complex generates the emission.9 Although the technology itself is not 
widely diffused and the production lines are still small, several companies such as LG, Konica 
or Philips are already producing OLEDs panels. They can be used to make flexible and 
transparent panels. 
The basic structure of an OLED consists of a thin film of an organic or material. The first diode 
of this type was reported by C. W. Tang and S. A. Van Slyke, the two chemists working at 
Eastman Kodak laboratories, in 1987.10 This first double heterostucture device (Figure 3) was 
made out of glass substrate coated with a transparent indium tin oxide (ITO) acting as anode; 
an aromatic diamine acting as a hole transporting layer; followed by a thin film of Alq3 
(Aluminium tris(8-hydroxyquinolinate)) acting as both emissive and electron transporting 
layers; and the Mg:Ag cathode at the top. 
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Figure 3. Configuration of OLED and molecular structures 
 
When an electrical current flows from cathode, through the organic materials, to the anode, 
positive and negative charges are injected into organic layers. The positive “holes” and the 
negative electrons recombine and form excitons inside the emissive layer (Figure 4). The 
electron-hole pairs so formed can be either in a singlet or in a triplet states. It depends on how 
the recombination occurs, but statistically the ratio is roughly 1:3 singlets to triplets.11 However, 
the singlets can undergo the intersystem crossing and became triplets as well, while the other 
way around is not possible. When the exciton decays, light is produced. 
 
Figure 4. Multilayer OLED structure 
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The OLEDs’ light quality is high and the response time is excellent. However, they are quite 
expensive and their lifetime sometimes is quite short, especially for the blue emitting OLEDs. 
They are sensitive to the environment, especially to water, so appropriate precautions should 
be taken, increasing the costs and complicating the manufacturing. 
 
3. NIR (Near Infrared) 
OLEDs does not include the visible spectrum only: more recently, there has been a growing 
interest in NIR-OLEDs. The devices made with molecules that emit in the IR region of the 
electromagnetic field may be used in different areas such as telecommunication, bioimaging, 
medical therapies and night vision equipment.12 
Infrared (IR) is a part of electromagnetic spectrum. The word comes from Latin, where “infra” 
means below; in fact, it has a longer wavelength than that of red light, which is the longest of 
visible light. It was discovered by a British astronomer, Sir William Herschel, in 1800. He used 
a glass prism to split the sunlight in its colour components. He found out that different colours 
have a different temperature, increasing from violet to red, but that the invisible part, just 
beyond the red portion, had the highest temperature.  
Infrared extends, roughly, from 750 nm to 1 mm. This region can be split into three smaller 
portions: Near-Infrared (NIR = 750 nm – 2500 nm), Mid-Infrared (MIR = 2500 nm – 25 μm) 
and Far Infrared (FIR = 25 μm – 1 mm). Lying outside of visible spectrum, Infrared light cannot 
be seen by human eyes; however, it can be seen with special cameras that translate it into visible 
colours. Infrared radiation is very important for the climate as well. The planet’s temperature is 
regulated by a balance between absorbed and emitted infrared radiation by the greenhouse 
gasses.13 
As mentioned before, the NIR technology may have many applications: for example, in food 
industries it is widely used as a quality control’s tool – through a fast analysis it is possible to 
measure the quantity of fat, proteins or sugar.  
Moreover, the near-infrared imaging is currently used in medicine and biology for diagnostics 
and therapeutic applications. Operating at long wavelength permits a deeper tissue penetration, 
together with a lower undesired absorption. In fact, in the wavelength range of 200 – 650 nm 
there is a number of blood and tissue components, such as melanin, haemoglobin (Hb) and 
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water, which have a high absorbance and thus, they can interfere with the analysis by creating 
a high background noise (Figure 5).14 However, the absorbance of these components 
considerably decreases after 650 nm, therefore it is much convenient to work in that range and 
luminophores able to emit in the NIR window are extremely attractive.   
 
 
Figure 5. Absorbance of various tissue and blood components 
 
4. Why Iridium? 
Transition metal complexes have found a large use within different branches of applied 
sciences, such as OLEDs and bioimaging technologies, but they also exhibit a broad range of 
biological activities, or can be used as catalysts in various reactions.15 Among transition metals 
derivatives, an important role is held by Ir(III) complexes, thanks to their robust nature, colour 
tunability, synthetic versatility and reversible electrochemistry.  
Cyclometalated Ir(III) complexes exhibit bright and tunable phosphorescent emission, thus 
resulting very attractive also for bioimaging. In fact, they feature some interesting properties 
for bioimaging applications, such as: high quantum yields at room temperature; tunable 
phosphorescent emission that covers all the visible spectra and, sometimes, NIR; large Stroke 
shifts; long emission lifetimes compatible with time-gated imaging, that eliminates the problem 
of autofluorescence and increase the sensibility; great photochemical and photophysical 
stabilities, along with and redox stability.16 Phosphorescent Ir(III) complexes can be therefore 
used for cellular imaging, intracellular sensing or cancer cell detection. The drawback of many 
10 
 
Ir(III) complexes, however, consists in their cytotoxicity, thus their delivery relies on 
biocompatible carriers.17 
The Ir(III) is a 5d6 transition metal and typically, the orbitals of d6 cations are destabilized and 
split, once coordinated, in an octahedral ligand field: t2g (dxy, dxz, dyz) and eg (dz2, dx2-y2). The 
energy gap between this two levels is called Δo (Figure 6). 
 
 
Figure 6. d6 octahedral field splitting 
 
The amount of energy Δo is smaller for the lower quantum numbers and bigger for the higher, 
because of different spatial extension of the orbitals. The other factor that influence the amount 
of Δo is the nature of the ligands. Different ligands exert different field strength and they can be 
ordered in a “spectrochemical series”. The oxidation state of the metal centre also plays an 
important role: the splitting is bigger for the higher oxidation states. 
Being a trivalent cation of the 6th period, Ir(III) benefits of high LFSE (ligand field stabilisation 
energy). It makes the dissociative eg orbitals less accessible and leads to an enhancement of the 
photostability. 
Ir(III) properties are similar to those of Fe(II) (3d6), Ru(II) (4d6), Os(II) (5d6) and Re(I) (5d6). 
However, Fe(II) has a small Δo splitting, so the lowest lying excited state is a non-emissive 
1MC 
state, centered on eg metal orbitals. In the case of Ru(II), the lowest emissive excited state is 
3MLCT in nature and it is close to the 3MC, which is not emissive. This latter state can be 
thermally populated and, as a consequence, the non-radiative decay became more competitive. 
In fact, PLQY of Ru(II) complexes is inversely proportional to the temperature. Os(II) is quite 
close to Ir(III) in terms of properties. However, the emissive 3MLCT state is very low in energy 
and in this case, radiationless paths governed by the “energy-gap law” become effective. 
Different possible transitions are illustrated in Figure 7. 
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Figure 7. Molecular orbitals and different transitions 
 
The high LFSE makes MC (Metal Centered) excited state less thermally accessible. Which is 
good, because 3MC state is non-emissive and undergoes the non-radiative decay, which in turn 
compromises the photoluminescence quantum yield.  
In principle, the emission colour of Ir(III) complexes can be tuned from blue to red through the 
appropriate modifications of the cyclometalating and/or ancillary ligands as described in the 
pioneering work of Prof. Thompson in 2001.18 , Figure 8 illustrates some Ir(III) based 
complexes with the emission along the whole visible spectrum.19 
 
Figure 8. Some structures of Ir(III) based complexes and their emission 
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5. Tuning the emission 
As mentioned before, through an accurate choice of the ligands, it is possible to tune the colour 
of emission of Ir(III) complexes. The colour depends on the HOMO-LUMO energy difference: 
a large energy gap corresponds to a blue-shifted emission, whereas a red-shifted emission 
originates from small energy gap.  
According to the nature of Ir(III) ligands, the complexes can be rationalized in two groups: 
 Homoleptic complexes, where three identical cyclometalating ligands are bond to 
the metal centre; 
 Heteroleptic complexes, where a different ligand substitutes one of the 
cyclometalating ligands.  
Homoleptic complexes can present two different geometries: facial (fac-) or meridional (mer-) 
isomers. The two possible geometries are illustrated in Figure 9. Facial is a thermodynamic 
isomer, thus more stable. Most of the reactions are run at high temperature, therefore mer- 
isomers are rarely obtained. 
 
 
Figure 9. Geometry of homoleptic complexes 
 
Heteroleptic complexes can be cationic, anionic or neutral, and the charge depends on the third 
ligand, which can be neutral, dianionic or monoanionic. 
Typically, in a heteroleptic Ir(III) complex, the HOMO orbital is located on the cyclometalated 
ligands, while the LUMO is found on the ancillary (third) ligand.7  
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Therefore, the emission of blue light, or rather the increase of the HOMO-LUMO gap, can be 
achieved by:  
 Introducing electron-withdrawing substituents on the cyclometalated ligands; 
 Adding electron-donating groups to the ancillary ligand; 
 Reducing the size of aromatic heterocycles; 
 Increasing the number of nitrogen atoms in the azole ring. 20  
Regarding the red emission, in order to reduce the HOMO-LUMO gap, it is possible to: 
 Add electron-withdrawing groups to the ancillary ligand;  
 Expand the π conjugation of both ligand systems; 
 Introduce electron-rich heteroaromatic rings in the cyclometalating ligand; 
Based on these observations, Bossi and co-workers reported a study on the 1(-
benzo[b]thiophen-2-yl)isoquinoline (Hiqbt) family of complexes.21 Thanks to the π conjugation 
of isoquinoline and benzotiophene groups and the presence of N and S atoms inside the 
aromatic rings it is possible to destabilize HOMO orbital. With the introduction of β-diketonate 
ancillary ligands, they obtained a slight red shift (10-15 nm) of the emission, compared to the 
corresponding tris-cyclometalated homoleptic complex. The ancillary ligands they used were: 
2,2,6,6-tetramethyl-3,5-heptanedione (Hdpm), 2-thienoyltrifluoroacetone (Htta) featuring one 
thiophenyl group and 1,3-di(thiophen-2-yl)propane-1,3-dione (Hdtdk) featuring two thiophenyl 
groups. All three complexes have a NIR phosphorescence around 700 nm (Figure 10).  
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Figure 10. (top) Structure of complexes; (left) Absorption spectra (at 298K);  
 (right) Emission spectra (at 298K) 
 
Another approach for the shift of the emission toward the red is that based on the stabilization 
of the LUMO, through the addition of electron-rich atom in the ancillary ligand. In this optic, 
Ortì and co-workers have recently reported a theoretical study describing the influence of azole 
rings on both cyclometalating and ancillary ligands.20 
Through DFT calculations, they investigated the relative change in HOMO-LUMO energy gap 
in a series of Ir(III) complexes with 2-phenylpyridine as cyclometalating ligand, through 
modifications of the structures of the ancillary ligand, in particular by changing the number and 
the position of nitrogen atoms in the azole moiety linked to 2-pyridine derivatives.  
In all the studied cases, calculations show that HOMO is mainly centred on the cyclometalating 
ligands and dπ orbitals of Ir(III), while the LUMO is centred on the π
* orbitals of the ancillary 
ligand. Moreover, it was observed that, by increasing the number of the N atoms in the azole 
ring, an effective stabilization of the LUMO is observed, while the HOMO is almost unaffected. 
This lead to a decrease of the HOMO-LUMO gap, as illustrated in Figure 11. 
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Figure 11. Energy diagram of the Ir(III) studied complexes 
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Purpose of the work 
As mentioned above, the interest in NIR emitting materials is constantly growing, for both 
OLED and bioimaging applications. In order to have an efficient NIR emission, the HOMO-
LUMO energy gap of the newly synthesized materials should be reduced, keeping in mind that, 
for small gaps, high photoluminescence quantum yield is very challenging. 
With the aim of synthesizing a new family of NIR emitting Ir(III) complexes, and based on the 
reported works by Bossi and Ortì,20,21 as well as on experimental studies performed in the 
research group where I worked, we envisaged the possibility to use for the first time 2-(1H-
tetrazol-1-yl)pyridine as a bidentate ligand able to provide the required energy gap in the final 
complexes.  
In detail, I used the 2-(1H-tetrazol-1-yl)pyridine ligand for the synthesis of a new family of 
heteroleptic cationic Ir(III) complexes 2N-4N, with typically ‘red emitter’ cyclometalated 
ligands, such as 2-methyl-3-phenylquinoxaline and 2-(1-benzothien-2-yl)pyridine, together 
with 1(-benzo[b]thiophen-2-yl)isoquinoline. The particular structure of these cyclometalating 
ligands should destabilize the HOMO orbital of the complexes, while the 2-(1H-tetrazol-1-
yl)pyridine ligand should stabilize the LUMO orbital, resulting in an overall reduction of the 
HOMO-LUMO energy gap. In addition, I synthetized complex 1N, containing 2-phenyl 
pyridine as cyclometalating ligand, to be used as reference compound. The structures of the 
investigated complexes are reported in Figure 12. 
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Figure 12. Cationic Ir(III) complexes 
 
Moreover, exploiting the particular structure of the 2-(1H-tetrazol-1-yl)pyridine ligand, I 
decided to investigate a second family of heteroleptic neutral Ir(III) complexes, in which the 
tetrazole fragment of the ligand act as a cyclometalating site (Figure 13). 
 
 
Figure 13. Neutral Ir(III) complexes 
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Results and discussion 
In order to synthesize the designed complexes, the work was divided in the following steps: 
1. Synthesis of some cyclometalating ligands 
2. Synthesis of Ir(III)-dimers 
3. Synthesis of 2-(1H-tetrazol-1-yl)pyridine 
4. Synthesis of cationic Ir(III) complexes 
5. Synthesis of neutral Ir(III) complexes 
Since the studies and methodologies of my thesis are subject of a possible patent, the description 
of the experimental work is in some cases summarized. 
 
1. Synthesis of cyclometalating ligands 
The derivatives I used as cyclometalating ligands are reported in Figure 14. 
Ligand 1 was used as a reference,22 since 2-phenylpyridine (Hppy) based complexes are the 
most popular, while the ligands 2-4 were chosen because of their capacity to red-shift the 
emission of the complexes to be obtained.21 
 
Figure 6. Structures of the selected cyclometalating ligands 
 
Ligands 1 and 3 were commercially available and were used without further treatment. On the 
contrary, ligands 2 and 4 had to be synthesized.  
Ligand 2 was obtained through the double condensation of 1,2-diaminobenzene and 1-phenyl-
1,2-propanedione in presence of I2 as catalyst (Scheme 1), following a described procedure.
23 
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Scheme 1. Synthetic procedure for ligand 2 
 
The reagents were dissolved in ACN and the mixture was stirred for an hour at room 
temperature. The solvent was removed in vacuum and the crude was purified on silica gel. 
NMR signals were in accordance with literature reported data and the product 2 was obtained 
in 93% yield.23 
Ligand 4 was obtained through the Suzuki’s coupling of 1-chloroisoquinoline and 
benzo[b]thiophen-2-yl-boronic acid,21 as reported in Scheme 2. 
 
 
Scheme 2. Synthetic procedure for ligand 4 
 
All the reagents were dissolved in THF and the reaction was stirred at 90oC for 16 hours in 
presence of 1M K2CO3
 solution in water. Pd(PPh3)4 was used as catalyst. Since Pd(0) catalysts 
are air sensitive, the reaction had to be performed under N2 atmosphere. After the work-up, the 
crude was purified on silica gel. Ligand 4 was obtained as white solid in 78.7% yield and NMR 
signals were in accordance with literature reported data.21  
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2. Synthesis of Ir(III) dimers 
Once all ligands were available, the corresponding Ir(III) dimers were synthesized following 
the general procedure reported by Nonoyama in 1974.24 IrCl3 x nH2O was reacted with 2 
equivalents of the appropriate cyclometalating ligand, giving the corresponding dimer, as 
reported in Scheme 3. 
 
Scheme 3. Synthetic procedure for dimers 1D-4D 
 
This cyclometalation reaction is a two-step process that consists in the binding of the donor 
group of the aromatic heterocycle of the ligand to the metal centre followed by intra-molecular 
cleavage of the C–H bond, forming the metal-containing cyclic framework.25 For this process 
to occur, high temperatures are required, therefore all reagents were dissolved in the 3:1 mixture 
of 2-ethoxyethanol and water and the mixture was refluxed under N2 atmosphere overnight. 
After this time, the dimer was formed as an insoluble solid. To achieve the complete 
precipitation, additional water was added. In the end, the solid was filtered and washed with 
water, hexane and Et2O in order to remove the impurities. The structures of the obtained Ir(III) 
dimers are reported in Figure 15. 
 
 
Figure 7. Structures of Ir(III) dimers 
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All the dimers are symmetric, so one series of signals, related to the single ligand should be 
expect from NMR analysis. Unfortunately, most of these dimers are poorly soluble in most 
common solvents: for example the NMR spectra of 2D was obtained in CDCl3, while for 3D 
the NMR spectra was acquired in DMSO. However, DMSO is a coordinating solvent able to 
easily react with the dimer, destroying its symmetry and giving as the result a second series of 
NMR peaks. Dimers 1D and 4D are not soluble in any common deuterated solvent, so it was 
not possible to acquire any NMR spectra and they were directly used in the next reactions, as 
in literature reported works.  
 
3. Synthesis of 2-(1H-tetrazol-1-yl)pyridine 
The next step was the synthesis of the versatile 2-(1H-tetrazol-1-yl)pyridine ligand. 
Considering the studies reported in the literature and illustrated in the introduction20,21 I 
identified ligand 5 (2-(1H-tetrazol-1-yl)pyridine) as the right precursor able to act both as a bis-
chelating (N^N) and a cyclometalating (C^N) ligand to potentially obtain NIR-emitting Ir(III) 
complexes. In fact, the particular disposition of the nitrogen atoms in the tetrazole ring should 
stabilize the LUMO orbitals of the formed complexes, taking it at lower energies (if confronted, 
for example, with 2,2-bipyridine) and shifting the emission toward shorter wavelength (red). 
The synthesis of the ligand is here reported (Scheme 4). 
 
Scheme 4. Synthetic procedure for ligand 5 
 
Following the procedure reported by Linert,26 2-aminopyridine, sodium azide and triethyl 
orthoformate were dissolved in glacial acetic acid and the solution was stirred at 80oC for 6 
hours. Acetic acid was removed in vacuum and the crude was dissolved in Et2O. The reaction 
was neutralized with NaHCO3. The formed solid was filter off and the organic layer was dried 
over Na2SO4. The solvent was removed in vacuum and the crude was recrystallized from EtOH. 
The final product was obtained in 62% yield as a white solid. NMR signals were in accordance 
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with literature reported data. The signals related to the protons of the pyridine ring can be found 
in the region between 8.55 and 7.43 ppm, while the signal related the H of the tetrazole ring 
appears as a singlet centred at 9.54 ppm, as reported in Figure 16.  
 
Figure 8. 1H NMR spectrum of 2-(1H-tetrazol-1-yl)pyridine 5 (CDCl3, 400 MHz) 
 
In addition to the electronic effects on the energy of molecular orbitals, a very interesting 
peculiarity of the obtained ligand is its versatility in acting as bidentate ligand. In fact, it can 
behave as coordinating ligand (N^N), but, interestingly, it can also be used as cyclometalating 
ligand (C˄N), (See Figure 17). In fact, it can lose its acidic proton when treated with a base.  
 
 
Figure 9. Coordination and cyclometalation sites 
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The main challenge however in using 5 as cyclometalating ligand is the identification of the 
right base able to assist the reaction. In fact, the tetrazolyl pyridine 5 appears to be quite 
sensitive to pH: in presence of a strong base, such as TBAOH, it reacts forming a new specie, 
N-(pyridin-2-yl)cyanamide. As soon as the base is added, visible bubbles are produced, by the 
escape from solution of N2 (Scheme 5).  
 
 
Scheme 5. Formation of N-(pyridin-2-yl)cyanamide 
 
The formation of the new specie was confirmed by NMR (Figure 18). All the aromatic peaks 
are still present, although they are significantly shifted to the higher fields. In detail, the former 
peaks appear now in the range between 7.90 to 6.40 ppm. Moreover, the singlet of the tetrazole 
ring disappeared and a newly formed amine group’s broad singlet at 5.30 ppm appeared.  
 
 
Figure 10. 1H NMR spectrum of N-(pyridin-2-yl)cyanamide (Acetone-d6, 400 MHz) 
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Looking for milder conditions, a detailed base screening was performed and finally I was able 
to find the optimal conditions to deprotonate ligand 5 (Scheme 6), as results from NMR analysis 
showing that over 95% of ligand was deprotonated (Figure 19). 
 
 
Scheme 6. Deprotonation of ligand 5 
 
 
Figure 11. 1H NMR spectrum of the deprotonated ligand 5 (Acetone-d6, 400 MHz) 
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4.  Synthesis of cationic Ir(III) complexes 
The first compounds I attempted to synthesize were cationic Ir(III) complexes 1N-4N, (Figure 
20), where the 2-(1H-tetrazol-1-yl)pyridine ligand coordinates the Ir(III) with two nitrogen 
atoms, acting as a N^N neutral ligand.  
 
Figure 12. Structures of cationic Ir(III) complexes 1N-4N 
 
First, I studied the synthesis of complex 1N. After performing a wide screening of reaction 
conditions, solvents and additives, I optimized the reaction and the purification procedures and 
obtained 1N in 66% yields.  
 
 
Scheme 7. Synthesis of complex 1N 
 
The formation of the desired complex was confirmed by NMR spectrometry (Figures 21-22) 
and HR-MS. In detail, in the 1H NMR spectrum the singlet of the CH of the tetrazole ring was 
shifted at 10.70 ppm, while the signals related to the two cyclometalated ligands appear not 
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equivalent, confirming the non-symmetric structure of the formed complex. The 13C NMR 
spectrum was consistent with the structure displaying the signals of all the not equivalent 
carbons. 
 
Figure 13. 1H NMR spectrum of 1N (Acetone-d6, 600 MHz) 
 
 
Figure 14. 13C NMR spectrum of 1N (bottom); DEPT (top) (Acetone-d6, 150 Mhz) 
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Following the optimized reaction condition for 1N, complex 2N was obtained in 96% yields, 
(Scheme 8). 
 
 
Scheme 8. Synthesis of complex 2N 
 
The NMR spectra of the purified product (Figure 23-24) were then acquired: the singlet of the 
CH of the tetrazole ring was shifted at 10.20 ppm in the 1H NMR spectrum, and in both spectra 
the signals related to the two cyclometalated ligands appear not equivalent, confirming the non-
symmetric nature of the product. HR-MS analysis was performed as well, to further confirm 
the formation of desired complex. 
 
Figure 15. 1H NMR spectrum of 2N (Acetone-d6, 600 MHz) 
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Figure 16. 13C NMR spectrum of 2N (bottom); DEPT (top) (Acetone-d6, 150 MHz) 
 
The same reaction conditions proved to be successful also in the synthesis of complex 3N, 
obtained in 67% yields, as reported in Scheme 9. 
 
 
Scheme 9. synthetic procedure for complex 3N 
 
After purification, the structure of 3N was confirmed by NMR spectroscopy (Figure 25 and 26) 
and HR-MS. Even in this case, the signals related to the two cyclometalated ligands appeared 
not equivalent and in the 1H NMR spectrum the singlet of the CH of the tetrazole ring was 
shifted at 10.75 ppm. 
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Figure 25:.1H NMR spectrum of 3N (Acetone-d6, 600 MHz) 
 
 
Figure 17. 13C NMR spectrum of 3N (bottom); DEPT (top) (Acetone-d6, 150 MHz) 
 
Unfortunately, complex 4N was more challenging to synthesize compared with the other 
analogous derivatives 1N-3N. In fact, despite several attempts, a satisfying amount of the 
desired product was never obtained. As first try, I used the same reaction conditions adopted 
for the previous complexes (Scheme 10), but the NMR analysis of the crude mixture indicated 
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the presence of many by-products, deriving either from the instability of the complex or from 
the presence of impurities within the starting dimer. Despite all the efforts for purification, the 
product was not isolated.  
Since an accurate structure analysis of the starting dimer was not possible owing to its 
insolubility, we hypothesized that problems occurred in its formation. So it was decided to 
approach different routes to the dimer 4D. However, all the attempts to react the so obtained 
4D with the ligand 5 was unsuccessful, since I always got complex reaction mixtures from 
which the desired product was never isolated. Studies are in progress to find better reaction 
conditions and purification procedures. 
 
 
Scheme 10. Attempted synthesis of complex 4N 
 
5. Synthesis of neutral Ir(III) complexes 
In the second part of my thesis I synthetized three neutral Ir(III) complexes 1C-3C where the 
2-(1H-tetrazol-1-yl)pyridine 5 act as a cyclometalating C^N ligand (Figure 27).  
The direct cyclometalation according to the procedure described by Thompson27 was attempted. 
However, since the methodology requires the use of high temperatures and, in some cases, of a 
base to promote the cyclometalation, I was aware that good results were difficult to obtain since 
2-(1H-tetrazol-1-yl)pyridine is a very sensitive ligand and at high temperature it either 
undergoes a complete breakdown or gives undesired reactions.  
As expected, the reaction of IrCl3 x nH2O salt with 2-(1H-tetrazol-1-yl)pyridine (5) in the 
refluxing mixture of 2-ethoxyethanol and water (130oC) didn’t yield the desired dimer. At the 
same time, the reaction of dimer 1C with ligand 5 in DCM and under reflux temperature gave 
a mixture of unknown products.  
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Figure 18. Generic structure of neutral complexes 
 
Therefore, a wide screening of reaction conditions was performed by varying the solvent, 
temperature and reagents. At the end, a general procedure for the synthesis of 1C and 2C was 
set up.  
Reaction of dimer 1D with ligand 5 under the appropriate condition gave complex 1C in 55% 
yields after purification (Scheme 13). 
 
 
Scheme 11. Synthesis of complex 1C 
 
The 1H NMR spectrum (Figure 28) was acquired and no singlet of the CH of the tetrazole ring 
was observed proving the cyclometalation, while the signals related to the other two 
cyclometalated ligands appear not equivalent, confirming the non-symmetric structure of the 
formed complex. 13C NMR spectrum was also acquired (Figure 29) to further confirm the 
structure of the complex. 
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Figure 19. 1H NMR spectrum of 1C (CDCl3, 400 MHz) 
 
 
Figure 29. 13C NMR spectrum of 1C (bottom); DEPT (top) (CDCl3, 150 MHz) 
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Similarly, complex 2C was obtained in 46% yields from the reaction of dimer 2D with ligand 
5, (Scheme 14). 
 
 
Scheme 12. Synthesis of  complex 2C 
 
The formation of the desired complex was confirmed by NMR spectrometry and HR-MS. In 
detail, as in the previous case, in the 1H NMR spectrum (Figure 30) the singlet of the CH of the 
tetrazole ring is missing and the signals related to the other two cyclometalated ligands appeared 
not equivalent, confirming the non-symmetric structure of the formed complex. The same 
conclusions can be deduced from the 13C NMR spectrum (Figure 31). 
 
Figure 30. 1H NMR spectrum of 2C (CDCl3; 600 MHz) 
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Figure 31. 13C NMR spectrum of 2C (bottom); DEPT (top) (CDCl3, 150 MHz) 
 
On the contrary, the synthesis of complex 3C was much more challenging. The procedure 
exploited for the synthesis of 1C and 2C did not give the desired results. A complex reaction 
mixture was obtained and I was not able to find the right conditions to perform the purification 
of 3C. Therefore, alternative reaction conditions were considered, and after various attempt, I 
was able to synthetize 3C in quantitative yield. 
 
 
Scheme 13. Synthesis of complex 3C 
 
The formation of the complex was confirmed by NMR spectrometry (Figure 32) and HR-MS. 
The singlet of the CH of the tetrazole ring was not observed in the 1H NMR spectrum proving 
the cyclometalation and the signals related to the two cyclometalated ligands appeared not 
equivalent, confirming the non-symmetric structure of the formed complex.  
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Figure 32. 1H NMR spectrum of 3C (Acetone-d6, 400 MHz) 
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6. Photophysical characterization 
The cationic iridium(III) complexes 1N, 2N and 3N are relatively unstable and/or insoluble in 
common spectroscopic solvents, consequently their photophysical characterization is not 
reported in the present thesis. Possible degradation pathways were investigated and the 
detachment of the N^N ligand from the iridium metal centre seems to be the main responsible. 
On the contrary, complexes 1C, 2C and 3C are stable in solution for days and do not show 
degradation under standard laboratory conditions. The following spectroscopic data were 
acquired: 
 Absorbance spectra in acetonitrile at 298 K 
 Emission spectra, PLQYs and excited-state lifetimes in acetonitrile at 298 K 
 Emission spectra and excited-state lifetimes in rigid matrix at 77K 
 Emission spectra, PLQYs and excited-state lifetimes in PMMA 
The room-temperature electronic absorption spectra of 1C-3C are reported in Figure 33. The 
spectral window between 225 and 300 nm shows intense absorption bands ( ≈ 2–9  104 M–1 
cm–1) that are tentatively assigned to spin-allowed ligand-centred (LC) π–π* electronic 
transitions involving the cyclometalating ligands.7 On the other hand, the weaker bands at a 
longer wavelength could also display a contribution from the iridium d orbitals and arise from 
transitions of both singlet and triplet spin multiplicity, due to the high spin–orbit coupling 
constant of the iridium metal centre. 
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Figure 33. Absorption spectra of 1C-3C in acetronitrile at 298 K. 
 
The room-temperature emission spectra of complexes 1C-3C in diluted acetonitrile solutions 
are reported in Figure 34. All complexes emit from a predominantly 3LC excited state with an 
important 3MLCT contribution from the iridium dπ orbitals. The ligand that is involved in the 
transition is always the one in trans to the cyclometalating site of ligand 5, as corroborated by 
the spin density plots of the lowest triplet state reported in Figure 35. The low values of the 
radiative decay constants (kr) reported in Table 1, further confirm this hypothesis (i.e., the kr of 
all the complexes are around 104 s–1, a value that is compatible with emission from 3LC excited 
states).7 Notably, the emission profile of complex 3C displays a strongly vibronically structured 
emission profile due to the presence of the 2-(benzo[b]thiophen-2-yl)pyridine cyclometalating 
ligands. In fact, a similar emission profile was also observed in an analogue neutral iridium(III) 
complex based on the same benzothiophene ligand, but having an acetylacetonate (acac) 
ancillary ligand instead of 5.28 
As experimentally observed, ligand 5 basically acts as a spectator ligand, therefore the emission 
properties of 1C–3C are effectively tuned by the other two cyclometalating ligands. As already 
observed for other iridium(III) complexes, the phenyl-quinoxaline (i.e., the ligand of 2C) is able 
to promote a strong red shift in the emission band of the related complex, if compared to 1C 
which is based on phenyl-pyridine cyclometalating ligands.29 
These experimental findings are in excellent agreement with DFT calculations; in fact, the 
estimated emission energies (calculated from the adiabatic energy difference between S0 and 
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T1) are computed to be 2.56 eV (483 nm), 1.88 eV (661 nm) and 2.08 eV (596 nm) for 1C, 2C 
and 3C, respectively (to be compared to spectroscopic data of Table 1). 
 
 
Figure 34. Normalized emission spectra of 1C-3C in acetonitrile solution at 298 K (full lines) 
and at 77 K (dashed lines). Excitation wavelength: 420 nm. 
 
 
Figure 35. Spin-density distributions calculated for the fully relaxed lowest triplet state (T1) 
of complexes 1C-3C in acetonitrile (surface isovalue = 0.002 e bohr–3). 
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Table 1.   Luminescence properties and photophysical parameters of C1–C3 in acetonitrile. 
 
Oxygen-free CH3CN solution, 298 K 
 Rigid matrix 
CH3CN, 77 K  
 
em
a 
[nm] 
PLQYb 
[%] 
 c 
[µs] 
kr 
d
 
[104 s–1] 
knr 
e
 
[106 s–1] 
 
em
a 
[nm] 
 c 
[µs] 
1C 525 1.4 1.2 1.2 0.82  504, 532(sh) 
0.9 (22%) 
4.0 (78%) 
2C 676 0.5 0.8 0.63 1.2  658 
3.7 (33%) 
8.9 (67%) 
3C 600, 650 7.6 4.9 1.6 0.19  598, 652 
5.2 (57%) 
12.3 (43%) 
a exc = 420 nm; b exc = 420 nm, [Ru(bpy)3]Cl2 aqueous solution as reference, PLQY = 2.8 %; c exc = 
365 nm; d kr = PLQY/; e knr = 1/ – kr. 
 
 
 
The photoluminescence quantum yields (PLQYs) of complexes 1C and 2C are relatively 
modest in room-temperature acetonitrile solution (i.e., around 1%) and only in the case of 
complex 3C a PLQY of 7.6% was recorded. This higher PLQY, compared to 1C and 2C, can 
be ascribed to a strong reduction in the non-radiative deactivation pathways (i.e., knr around 10
5 
vs. 106 s–1, see Table 1), rather than to a different nature of the emitting state. The remarkably 
high values of knr observed for this series of complexes deserve a more accurate photophysical 
investigation (e.g., temperature dependent studies and/or a more detailed theoretical analysis of 
thermally accessible triplet excited states); these investigations are ongoing. In fact, similar 
cyclometalated iridium(III) complexes are known to display low PLQYs due to the presence of 
low-lying metal centred (3MC) states that are able to effectively quench their luminescence.30 
At 77 K, all the complexes show bright emission. This experimental evidence is actually an 
additional indication suggesting that, at room temperature, thermally activated processes can 
be responsible for emission quenching. At low temperature, all emission spectra display a 
negligible blue shift compared to 298 K data, which is a further indication that the emissive 
state in all complexes has a strong 3LC character, with a little 3MLCT contibution. This is 
particularly true in the case of complex 3C, where the emission at 77 K is practically 
superimposable with the one at 298 K. 
The emission properties of 1C-3C were also investigated in the solid state (i.e., in PMMA 
matrix at a concentration of 1% by weight and in neat films). 
In PMMA matrix, an increase of PLQYs is generally observed for all the complexes, if 
compared to data in room-temperature solutions (see Table 2 and Table 1). The emission 
profiles are very similar to the ones already recorded in acetonitrile (compare Figure 36 and 
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34), suggesting that the emitting state responsible for the luminescence in the solid state is the 
same of the solution. 
 
Figure 36. Normalized emission spectra of 1C-3C in PMMA 1% wt. at 298 K (dotted lines), 
compared with the associated spectra in acetonitrile solution at 298 K (full lines). Excitation 
wavelength: 420 nm. 
 
Table 2.   Luminescence properties and photophysical parameters of 1C-3C in solid state 
(PMMA 1% wt.) at 298 K. 
 
em
a 
[nm] 
PLQYb 
[%] 
 c 
[µs] 
kr 
d
 
[104 s–1] 
knr 
e
 
[105 s–1] 
1C 510 2.7 1.4 1.9 6.9 
2C 645 13.0 1.1 11.8 7.9 
3C 600, 650 16.8 7.0 2.4 1.2 
a exc = 420 nm; b exc = 420 nm, determined using an integrating 
sphere; c exc = 365 nm; d kr = PLQY/; e knr = 1/ – kr. 
 
 
On the other hand, in neat film, no emission is detected (i.e., PLQY < 0.1%). This could be 
potentially attributable to self-quenching due to the high concentration of the emitter, a 
phenomenon that is commonly observed in the case of cyclometalated iridium(III) complexes 
lacking of bulky substituents.7 
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Conclusions 
During my thesis, I spent most of the time in performing synthetic experimental work in the 
lab, finding the right reaction and purification conditions and currently the project is still in 
progress.  
I had successfully synthesized all of the required ligands in good yields and purity.  
I have developed efficient synthetic methods for the preparation of three cationic Iridium(III) 
complexes, 1N-3N, in which  2-(1H-tetrazol-1-yl)pyridine acts as N^N bis-chelating ligand and 
three neutral Iridium(III) complexes, 1C-3C, in which  2-(1H-tetrazol-1-yl)pyridine acts as 
C^N cyclometalating ligand. Unfortunately, any attempt to obtain pure complex 4N failed. 
All the compounds were characterized with NMR spectroscopy and MS spectrometry.  
Concerning the photophysical properties, only neutral complexes 1C-3C resulted stable under 
standard experimental conditions and were fully investigated. 
From computational and photophysical analysis, ligand 2-(1H-tetrazol-1-yl)pyridine proved to 
basically behave as a spectator ligand and could not dramatically shift the emission of the 
obtained complexes towards NIR wavelengths. 
Studies are in progress to find a viable route to 4N complex and to perform the photophysical 
characterizations of the cationic complexes.  
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Experimental section 
1. Materials and methods 
1H, 13C and 19F NMR spectra were recorded on a Varian AS 300, on a Mercury 400 or a Varian 
AS 600 spectrometer. All spectra were acquired at 25oC, unless otherwise specified. 
Chemical shifts (δ) are reported in ppm relative to residual solvent signals for 1H and 13C NMR: 
Solvent  1H NMR (ppm)  13C NMR (ppm)  
CDCl3  7.26  77.0  
Acetone-d6 2.05  29.9  
DMSO  2.50  39.5  
 
13C NMR spectra were acquired with 1H broadband decoupled mode. The types of carbon atoms 
were determined by DEPT NMR experiments. To indicate the multiplicity were used the 
following abbreviations: s, singlet; d, doublet; t, triplet; dd, double doublet; dt, double triplet; 
m, multiplet. Analytical grade solvents and commercially available reagents were used as 
received, unless otherwise stated. Chromatographic purifications were performed using 230-
400 mesh silica and 70-290 mesh Al2O3. 
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2. Synthesis 
2.1. Synthesis of ligands 
2.1.1. Synthesis of 2-methyl-3-phenylquinoxaline (2) 
 
1,2-benzenediamine (650 mg; 6 mmol; 1.2 equiv) and 1-phenyl-1,2-propanedione (673 μL; 5 
mmol; 1 equiv) were dissolved in acetonitrile (3 mL). Iodine (126 mg; 0.3 mmol; 0.1 equiv) 
was added and the mixture was stirred for 1h at rt. The solvent was removed in vacuum and the 
resulting yellowish solid was purified by flash chromatography on silica gel (Hexane:Ethyl 
acetate = 6:1) giving the product as an off-white solid (1.02 g; 93.0% yield). NMR signals are 
in accordance with literature reported data.23 
1H NMR (CDCl3, 300 MHz) δ 8.15-8.02 (m, 2H), 7.77-7.69 (m, 2H), 7.69-7.63 (m, 2H), 7.57-
7.47 (m, 3H), 2.78 (s, 3H). 
 
2.1.2. Synthesis of 1(-benzo[b]thiophen-2-yl)isoquinoline (4) 
 
 
1-chloroisoquinoline (500 mg; 3.05 mmol; 1 equiv) and benzo[b]thiophen-2-yl-boronic acid 
(545 mg; 3.06 mmol; 1 equiv) were dissolved in THF (12 mL) under N2 atmosphere. Then a 
1M K2CO3
 solution in water (12 mL) was added, followed by Pd(PPh3)4 (176 mg; 0.15 mmol; 
0.05 equiv). The reaction was stirred at 90oC for 16h. The organic layer was then separated and 
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the aqueous layer was extracted with DCM (3 x 10 mL). The organic layers were combined, 
dried over Na2SO4, concentrated and the crude was purified by flash chromatography on silica 
gel (Hexane:Ethyl Acetate = 95:5) giving the product as a white solid (627 mg; 78.7% yield). 
NMR signals are in accordance with literature reported data.21 
1H NMR (CDCl3, 400 MHz) δ 8.63 (d, JHH = 1.0 Hz, 1H), 8.62 (d, JHH = 5.7 Hz, 1H), 7.95-7.88 
(m, 3H), 7.85 (s, 1H), 7.76-7.72 (m, 1H), 7.68 (d, JHH = 1.4 Hz, 1H), 7.67-7.64 (m, 1H), 7.43-
7.40 (m, 2H). 
13C NMR (CDCl3, 100 MHz) δ 153.7 (C), 143.1 (C), 142.4 (CH), 140.9 (C), 140.3 (C), 137.2 
(C) 130.4 (CH), 128.0 (CH), 127.5 (CH), 126.8 (CH), 126.6 (C), 125.6 (CH), 125.3 (CH), 124.6 
(CH), 124.4 (CH), 122.5 (CH), 120.6 (CH). 
GC-MS: m/z = 259 (100%), 130 (26%). 
 
2.1.3. Synthesis of 2-(1H-tetrzol-1-yl)pyridine (5) 
 
 
2-Aminopyridine (0.94 g; 10 mmol; 1 equiv), sodium azide (1.33 g; 20 mmol; 2 equiv) and 
triethyl ortoformate (5 mL; 30 mmol; 3 equiv) were dissolved in glacial acetic acid (4.6 mL; 80 
mmol; 8 equiv). The solution was stirred at 80oC for 6h. Acetic acid was removed in vacuum 
and the crude was dissolved in Et2O. NaHCO3 was added until the evolution of CO2 ceased. 
The formed solid was filter off and the ether layer was dried over Na2SO4. The solvent was 
removed in vacuum and the crude was recrystallized from EtOH. The final product was 
obtained in 62% yield (0.91 g) as white crystals.  
1H NMR (CDCl3, 400 MHz) δ 9.54 (s, 1H), 8.55 (d, JHH = 4.9 Hz, 1H), 8.10 (dd, JHH = 0.9 Hz, 
JHH = 8.2 Hz, 1H), 8.02-7.97 (m, 1H), 7.47-7.43 (m, 1H). 
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2.2. Synthesis of Ir(III) dimers 
General procedure of synthesis 
 
Under N2 atmosphere, IrCl3 x nH2O (1 equiv) and desired ligand (2.5 equiv) were dissolved in 
a 3:1 mixture of 2-ethoxyethanol and H2O (4 mL). The solution was refluxed overnight. After 
this time, water (5 mL) was added and the formed coloured solid was filtered on Büchner and 
washed with water (2 times x 5 mL), Et2O (2 times x 5 mL) and Hexane (2 times x 5 mL).  
 
2.2.1. Synthesis of dimer 1D 
 
 
Following the general procedure, the reaction of IrCl3 x nH2O (50 mg; 0.167 mmol; 1 equiv) 
with 2-phenylpyridine (65 mg; 0.418 mmol; 2.5 equiv) in a 3:1 mixture of 2-ethoxyethanol and 
H2O gave 1D as a yellow solid (63.7 mg; yield 71.3%). The crude dimer was used in the next 
step without further purifications. 
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2.2.2. Synthesis of dimer 2D 
 
 
Following the general procedure, the reaction of IrCl3 x nH2O (150 mg; 0.50 mmol; 1 equiv) 
with 2-methyl-3-phenylquinoxaline (2) (275 mg; 1.25 mmol; 2.5 equiv) in a 3:1 mixture of 2-
ethoxyethanol and H2O gave 2D as a red solid (222.8 mg; yield 67.0%). The crude dimer was 
used in the next step without further purifications. 
1H NMR (CDCl3, 400 MHz) δ 8.15 (d, JHH = 8.9 Hz, 4H), 7.95 (d, JHH = 7.8 Hz, 4H), 7.68 (dd, 
JHH = 8.4 Hz, JHH = 0.9 Hz, 4H), 7.56 (t, JHH = 7.2 Hz, 4H), 6.93-6.78 (m, 8H), 6.31 (t, JHH = 
7.6 Hz, 4H), 5.75 (d, JHH = 7.8 Hz, 4H), 3.18 (s, 12H). 
 
2.2.3. Synthesis of dimer 3D 
 
 
Following the general procedure, the reaction of IrCl3 x nH2O (300 mg; 1.0 mmol; 1 equiv) 
with 2-(1-benzothien-2-yl)pyridine (3) (530 mg; 2.5 mmol; 2.5 equiv) in a 3:1 mixture of 2-
ethoxyethanol and H2O gave 3D as an orange solid (461.9 mg; yield 71.3%). The crude dimer 
was used in the next step without further purifications. 
1H NMR (DMSO, 300 MHz) δ 9.93 (d, JHH = 6.0 Hz, 1H), 9.69 (d, JHH = 6.0 Hz, 1H), 8.19 (dt, 
JHH = 1.6 Hz, JHH = 7.8 Hz, 1H), 8.10 (dt, JHH = 1.6 Hz, JHH = 7.8 Hz, 1H), 7.93 (d, JHH = 8.2 
Hz, 1H), 7.83 (d, JHH = 8.2 Hz, 1H), 7.78 (d, JHH = 8.0 Hz, 2H), 7.56-7.50 (m, 1H), 7.48-7.42 
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(m, 1H), 7.22-7.16 (m, 1H), 7.15-7.09 (m, 1H), 6.94-6.88 (m, 1H), 6.82-6.75 (m, 1H), 6.19 (d, 
JHH = 8.2 Hz, 1H), 5.56 (d, JHH = 8.2 Hz, 1H). 
 
2.2.4. Synthesis of dimer 4D 
 
 
Following the general procedure, the reaction of IrCl3 x nH2O (50 mg; 0.167 mmol; 1 equiv) 
with 1(-benzo[b]thiophen-2-yl)isoquinoline (4) (109 mg; 0.419 mmol; 2.5 equiv) in a 3:1 
mixture of 2-ethoxyethanol and H2O gave 4D as a brown solid (78.4 mg; yield 62.8%) insoluble 
in all common deuterated solvents available in the laboratory. The crude dimer was used in the 
next step without further purifications. 
 
2.3. Synthesis cationic Ir(III) complexes 
2.3.1. Synthesis of 1N 
 
Following the general procedure I set up, complex 1N was obtained as a yellow solid in 65.7% 
yield (21.3 mg).  
1H NMR (Acetone-d6, 600 MHz) δ 10.71 (s, 1H), 8.80 (d, JHH = 8.4 Hz, 1H), 8.55 (t, JHH = 8.2 
Hz, 1H), 8.27 (d, JHH = 8.4 Hz, 1H), 8.25 (d, JHH = 8.4 Hz, 1H), 8.05-7.9 (m, 4H), 7.93-7.90 
(m, 2H), 7.87-7.83 (m, 2H), 7.21 (t, JHH = 6.8 Hz, 1H), 7.16 (t, JHH = 6.8 Hz, 1H), 7.08 (t, JHH 
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= 7.2 Hz, 1H), 7.01 (t, JHH = 7.2 Hz, 1H), 6.95 (t, JHH = 7.2 Hz, 1H), 6.88 (t, JHH = 7.2 Hz, 1H), 
6.32-6.29 (m, 2H). 
13C NMR (Acetone-d6, 150 MHz) δ 168.7 (C), 167.7 (C), 151.4 (CH), 151.0 (CH), 150.7 (CH), 
147.0 (C), 146.6 (C), 145.2 (C), 145.0 (C), 144.6 (C), 143.6 (CH), 140.2 (CH), 140.1 (CH), 
132.7 (CH), 132.1 (CH), 131.4 (CH), 130.7 (CH), 129.32 (CH), 129,31 (CH), 126.0 (CH), 125.5 
(CH), 124.8 (CH), 124.4 (CH), 124.2 (CH), 123.7 (CH), 121.0 (CH), 120.9 (CH), 117.5 (CH).  
19F NMR (Acetone-d6, 376 MHz) δ -155.0. 
 
2.3.2. Synthesis of 2N 
 
Following the general procedure, complex 2N was obtained as a red solid in 96.4% yield (41.6 
mg). 
1H NMR (Acetone-d6, 600 MHz) δ 10.20 (s, 1H), 8.58 (d, JHH = 7.9 Hz, 1H), 8.54 (d, JHH = 5.6 
Hz, 1H), 8.49 (d, JHH = 8.1 Hz, 1H), 8.34 (dt, JHH = 1.5 Hz, JHH = 7.9 Hz, 1H), 8.26 (d, JHH = 
8.5 Hz, 1H), 7.92-7.89 (m, 3H), 7.67-7.64 (m, 1H), 7.62 (d, JHH = 9.1, 1H), 7.61-7.58 (m, 1H), 
7.37-7.33 (m, 2H), 7.31-7.26 (m, 2H), 7.17-7.15 (m, 1H), 6.94 (dt, JHH = 1.0 Hz, JHH = 7.4 Hz, 
1H), 6.89-6.86 (m, 2H), 6.75 (dd, JHH = 0.7 Hz, 1H), 3.41 (s, 3H), 3.37 (s, 3H). 
13C NMR (Acetone-d6, 150 MHz) δ 165.6 (C), 164.5 (C), 153.8 (C), 153.7 (C), 150.2 (C), 148.5 
(CH), 147.4 (C), 146.6 (C), 145.9 (C), 145.6 (C), 145.2 (CH), 144.0 (CH), 141.3 (C), 141.1 (C), 
140.9 (C), 140.7 (C), 136.8 (CH), 136.4 (CH), 131.84 (CH), 131.82 (CH), 131.6 (CH), 131.3 
(CH), 131.2 (CH), 131.1 (CH), 131.0 (CH), 130.7 (CH), 130.1 (CH), 130.0 (CH), 129.5 (CH), 
125.0 (CH), 124.9 (CH), 124.8 (CH), 124.6 (CH), 117.1 (CH), 27.5 (CH3), 27.4 (CH3). 
19F NMR (Acetone-d6, 376 MHz) δ -155.0. 
HRMS calcd for C36H27IrN9
+: 776.1990; found: 776.2014 [M-BF4]
+. 
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2.3.3. Synthesis of 3N 
 
Following the general procedure, complex 3N was obtained as an orange solid in 67.4% yield 
(26 mg). 
1H NMR (Acetone-d6, 600 MHz) δ 10.75 (s, 1H), 8.85 (d, JHH = 8.3 Hz, 1H), 8.56 (dt, JHH = 
1.7 Hz, JHH = 8.0 Hz, 1H), 8.12-8.07 (m, 3H), 8.02 (d, JHH = 5.7 Hz, 1H), 7.97 (dt, JHH = 1.0 
Hz, JHH = 5.7 Hz, 1H), 7.95 (dt, JHH = 1.1 Hz, JHH = 8.0 Hz, 1H), 7.90 (dt, JHH = 1.1 Hz, JHH = 
8.1 Hz, 1H), 7.88 (dt, JHH = 0.8 Hz, JHH = 8.2 Hz, 1H), 7.84 (dd, JHH = 1.1 Hz, JHH = 7.6 Hz, 
1H), 7.83 (d, JHH = 8.0 Hz, 1H), 7.25-7.23 (m, 1H), 7.21-7.19 (m, 1H), 7.15-7.13 (m, 1H), 7.10-
7.08 (m, 1H), 6.93-6.87 (m, 2H), 6.08 (d, JHH = 8.2 Hz, 2H). 
13C NMR (Acetone-d6, 150 MHz) δ 165.6 (C), 164.7 (C), 152.5 (CH), 152.1 (CH), 151.5 (CH), 
146.8 (C), 146.43 (CH), 146.40 (C), 145.5 (C), 144.3 (CH), 143.3 (C), 143.01 (C), 143.00 (C), 
141.61 (CH), 141.60 (CH), 141.3 (C), 138.0 (C), 137.7 (C), 129.8 (CH), 126.8 (CH), 126.5 
(CH), 125.6 (CH), 125.5 (CH), 125.4 (CH), 125.1 (CH), 124.2 (CH), 124.1 (CH), 123.0 (CH), 
122.5 (CH), 120.8 (CH), 120.6 (CH), 117.9 (CH). 
19F NMR (Acetone-d6, 376 MHz) δ -155.0. 
HRMS calcd for C32H21IrN7S2
+: 758.0900; found: 758.0909 [M-BF4]
+. 
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2.4. Synthesis neutral Ir(III) complexes 
2.4.1. Synthesis of 1C 
 
 
Following the general procedure I developed, complex 1C was obtained as a yellow solid in 
55.2% yield (10 mg). 
1H NMR (CDCl3, 600 MHz) δ 8.99 (d, JHH = 5.8 Hz, 1H), 8.00 (d, JHH = 5.8 Hz, 1H), 7.91 (d, 
JHH = 8.0 Hz, 1H), 7.85 (d, JHH = 8 Hz, 1H), 7.77 (d, JHH = 7.3 Hz, 1H), 7.75 (d, JHH = 7.3 Hz, 
1H), 7.58-7.50 (m, 3H), 7.44 (d, JHH = 5.3 Hz, 1H), 7.21 (t, JHH = 6.5 Hz, 1H), 7.05 (t, JHH = 
6.5 Hz, 1H), 6.87-6.82 (m, 3H), 6.72 (d, JHH = 7.2 Hz, 1H), 6.69 (d, JHH = 7.2 Hz, 1H), 6.60 (t, 
JHH = 6.3 Hz, 1H), 6.21 (d, JHH = 7.8 Hz, 1H), 6.16 (d, JHH = 7.8 Hz, 1H). 
13C NMR (CDCl3, 150 MHz) δ 169.6 (C), 169.0 (C), 167.8 (C), 151.1 (CH), 149.2 (CH), 148.2 
(C), 144.6 (CH), 144.13 (C), 144.11 (C), 143.7 (C), 138.3 (CH), 137.3 (CH), 137.1 (CH), 132.3 
(CH), 132.1 (CH), 129.6 (CH), 129.5 (CH), 124.2 (CH), 124.0 (CH), 122.7 (CH), 122.3 (CH), 
121.6 (CH), 121.3 (CH), 119.0 (CH), 118.5 (CH), 118.4 (C), 114.6 (CH), 113.4 (CH). 
 
2.4.2. Synthesis of 2C 
 
 
Following the general procedure, complex 2C was obtained as a red solid in 46.4% yield (8 
mg). 
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1H NMR (CDCl3, 600 MHz) δ 8.30 (d, JHH = 8.8 Hz, 1H), 8.28 (d, JHH = 8.3 Hz, 1H), 8.25 (d, 
JHH = 8.1 Hz, 1H),  8.02 (d, JHH = 8.3 Hz, 1H), 7.96 (d, JHH = 8.1 Hz, 1H), 7.66-7.64 (m, 2H), 
7.60 (t, JHH = 7.5 Hz, 1H), 7.52 (t, JHH = 7.5, 1H), 7.35 (d, JHH = 5.4, 1H), 7.14-7.09 (m, 3H), 
7.06 (t, JHH = 7.7 Hz, 1H), 6.74 (t, JHH = 7.4 Hz, 1H), 6.69 (t, JHH = 7.4 Hz, 1H), 6.65 (d, JHH = 
7.4 Hz, 1H), 6.44-6.40 (m, 2H), 6.23 (d, JHH = 8.8 Hz, 1H), 3.39 (s, 3H), 3.35 (s, 3H). 
13C NMR (CDCl3, 150 MHz) δ 167.5 (C), 164.4 (C), 163.2 (C), 152.3 (C), 152.1 (C), 151.1 
(C), 150.4 (C), 145.0 (C), 144.5 (C), 142.1 (CH), 140.4 (C), 140.2 (C), 140.15 (C), 140.14 (C), 
138.2 (CH), 136.1 (CH), 135.5 (CH), 130.5 (CH), 130.0 (CH), 129.7 (CH), 129.6 (CH), 129.5 
(CH), 129.2 (CH), 129.1 (CH), 128.99 (CH), 128.96 (CH), 128.1 (CH), 127.3 (CH), 125.7 (CH), 
122.4 (CH), 122.0 (CH), 116.1 (C), 114.4 (CH), 112.6 (CH), 27.4 (CH3), 27.3 (CH3). 
HRMS calcd for C36H26IrN9: 776.1940; found: 776.2014. 
 
2.4.3. Synthesis of 3C 
 
Following the procedure I developed for this compound, complex 3C was isolated as an orange 
solid in quantitative yield (20 mg). 
1H NMR (Acetone-d6, 400 MHz) δ 9.19-9.17 (m, 1H), 8.38-8.35 (m, 1H), 8.13-8.06 (m, 2H), 
7.96-7.91 (m, 1H), 7.89-7.85 (m, 2H), 7.80-7.77 (m, 1H), 7.73-7.70 (m, 2H), 7.50 (d, JHH = 8.7 
Hz, 1H), 7.34-7.26 (m, 2H), 7.17-7.11 (m, 2H), 6.91-6.82 (m, 3H), 6,14 (d, JHH = 6.1 Hz, 1H), 
6.04 (d, JHH =8.3 Hz, 1H). 
HRMS calcd for C32H20IrN7S2: 758.0900; found: 758.0909. 
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3. Spectroscopic methods 
The spectroscopic investigations were carried out in spectrofluorimetric grade acetonitrile. The 
absorption spectra were recorded with a Perkin-Elmer Lambda 950 spectrophotometer. For the 
photoluminescence experiments, the sample solutions were placed in fluorimetric Suprasil 
quartz cuvettes (1 cm path length) and dissolved oxygen was removed by bubbling argon for 
20 minutes. The uncorrected emission spectra were obtained with an Edinburgh Instruments 
FLS920 spectrometer equipped with a Peltier-cooled Hamamatsu R928 photomultiplier tube 
(PMT) (185−850 nm) and a R5509–72 supercooled PMT for the NIR spectral windows (800–
1700 nm). An Edinburgh Xe 900 (450 W xenon arc lamp) was used as the excitation light 
source. The corrected spectra were obtained via a calibration curve supplied with the 
instrument. The photoluminescence quantum yields (PLQY) in solution were obtained from the 
corrected spectra on a wavelength scale (nm) and measured according to the approach described 
by Demas and Crosby31 using an air-equilibrated water solution of [Ru(bpy)3]Cl2 (PLQY = 
2.8%)32 as reference. The emission lifetimes (τ) were measured through the time-correlated 
single photon counting (TCSPC) technique using an HORIBA Jobin Yvon IBH FluoroHub con-
trolling a spectrometer equipped with a pulsed NanoLED (λexc = 465 nm) or a SpectraLED (λexc 
= 370 nm) as excitation source, depending on the measured emission lifetime, and a red-
sensitive Hamamatsu R-3237-01 PMT (185–850 nm) as detector. The analysis of the 
luminescence decay profiles was accomplished with the DAS6 Decay Analysis Software 
provided by the manufacturer, and the quality of the fit was assessed with the χ2 value close to 
unity and with the residuals regularly distributed along the time axis. To record the 77 K 
luminescence spectra, samples were put in glass tubes (2 mm inner diameter) and inserted into 
a special quartz Dewar flask filled with liquid nitrogen. Solid samples were prepared by drop 
casting using a dichloromethane-acetone solution (2:1) containing the poly(methyl 
methacrylate) (PMMA) matrix with 1% wt. of the complex; the thickness of the films was not 
controlled. Solid-state PLQY values were calculated by corrected emission spectra obtained 
from an Edinburgh FLS920 spectrometer equipped with a barium sulphate-coated integrating 
sphere (diameter of 4 in.) following the procedure described by Würth et al.33 Experimental 
uncertainties are estimated to be ±5% for τ determinations, ±10% for PLQY, ±2 nm and ±5 nm 
for absorption and emission peaks, respectively. 
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4. Computational details 
Density functional theory (DFT) calculations were carried out using the D.01 revision of the 
Gaussian 09 program package34 in combination with the M06 hybrid meta exchange-correlation 
functional.35 The 6-31G(d,p) basis set was selected for C, H and N;36 the small-core relativistic 
energy-consistent pseudopotentials (PPs) of the Stuttgart/Cologne group was used, along with 
its triple-ζ correlation-consistent basis sets for the iridium metal centre (ECP60MDF/VTZ basis 
set).37 All the complexes were fully optimised, without symmetry constraints, in acetonitrile 
both in the electronic ground state (S0) and in the lowest triplet state (T1) by using the polarisable 
continuum model (PCM).38 A frequency calculation was always used to confirm that the 
stationary point found by the geometry optimisation was actually corresponding to a mini-mum 
on the potential energy surface (no imaginary frequencies). To investigate the nature of the T1 
state, geometry optimisations and related frequency calculations were performed at the spin-
unrestricted UM06 level of theory, imposing a spin multiplicity of 3. All the pictures of 
molecular orbitals and spin-density surfaces were created using GaussView 5.39 
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